1

BUREAU OF PHARMA PUBLIC SECTOR UNDERTAKINGS OF INDIA (BPPI)

(Set up the under the Dept. of Pharmaceuticals, Govt. of India)

Regd. Off.: Core No. 6, First Floor, SCOPE complex, Lodhi Road, New Delhi-110003

Working Office: IDPL Corporate Office, IDPL Complex, Old Delhi-Gurgaon Road,

Dundahera, Gurgaon-122016 (Haryana)

Phone numbers: 0124-4556751/ 52 Fax: 0124-2340370

e-mail : ceo.bppi@gmail.com; kchopra.bppi@gmail.com

Website: janaushadhi.gov.in

TENDER FOR EMPANELMENT OF ANALYTICAL TESTING

LABORATORIES FOR THE ANALYSIS OF DRUGS AND

MEDICINES FOR THE YEAR 2014-2015

Tender Reference Number: BPPI/Drug Testing/004. Dt. 23/12/2013

Date of availability of Tender documents on website: 23/12/2013

Last date and time for receipt of Tender : 06/01/2014 at 15.00 hrs

Date and time of Opening of Tender : 06/01/2014 at 15.30 hrs

Place of Opening of Tender : BPPI, IDPL Corporate Office, IDPL

Complex, Dundahera, Gurgaon (HR)

Address For Communication : BPPI, IDPL Corporate Office, IDPL

Complex, Dundahera, Gurgaon (HR)

Contact Person for clarification if any: 1. Mr. K. Chopra,

Officer on Special Duty

0124-4040759, M-9711003043

Email: kchopra.bppi@gmail.com

2. Mr. Mahadev Agarwal,

Manager (Regulatory)

0124-4556756, M-9873294473

Email: mahadevpharm.bppi@gmail.com

2

CONTENTS

Sl. No. Description Page No.

1 Last date for receipt of Tender 04

2 Eligibility Criteria 04

3 Earnest Money Deposit 05

4 Technical Bid – Cover -‘A’ 05

5 Price Bid – Cover -‘B’ 08

6 General Conditions 09

7 Acceptance of Tender 10

8 Opening of Cover -‘A’ and Cover-‘B’ of tender 10

9 Agreement 11

10 Security Deposit 11

11 Complete Analysis and Reporting Condition 12

12 Payment Provisions 15

13 Penalties Provisions 15

14 Black Listing Procedure 16

15 Jurisdiction 17

16 Agreement Format 17

17 Annexure-I : Proforma for Performance Statement 27

3

18 Annexure –II : Details of Laboratory and Certificate of

Registration for Service Tax

28

19 Annexure-III (A) Personnel in Laboratory 29

20 Annexure-III (B) List of Sophisticated Instruments 29

21 Annexure-III (C) Facilities in Microbiological Section 30

22 Annexure-IV: Declaration Form 31

23 Annexure V : List of Drugs and Medicines 32

24 Annexure VI : Checklist 49

25 Annexure VII : Cover -‘B’ (Price Bid) in a separate

cover

52

4

BUREAU OF PHARMA PUBLIC SECTOR UNDERTAKINGS OF INDIA (Set up under dept. of Pharmaceuticals, Govt. of India)

TENDER FOR EMPANELMENT OF ANALYTICAL TESTING

LABORATORIES FOR THE ANALYSIS OF DRUGS AND MEDICINES

FOR BPPI FOR THE YEAR 2014-15 FROM THE DATE OF

ACCEPTANCE OF TENDER

“CONFIDENTIALITY IS THE ESSENCE OF THIS TENDER”

1. Sealed tenders will be received till 06/01/2014 upto 15.00 hour by General

Manager (A&F) at Bureau of Pharma Public Sector Undertakings of

India (BPPI), IDPL Corporate Office, IDPL Complex, Dundahera,

Gurgaon-122016 (Haryana), (Herein referred as Tender inviting

authority unless the context otherwise requires) for Empanelment of

Analytical Testing Laboratories for the Analysis of Drugs and Medicines

for Period of Two Years from the date of acceptance of tender by BPPI. The

tender may be extended for further period on mutually agreed terms.

2. (a) Only National Accreditation Board for Testing and Calibration

Laboratories (NABL) accredited analytical laboratories having license under

the Drugs and Cosmetics Act, with minimum two years experience in the

analysis of Drugs and medicines with an minimum average annual turnover of

5

Rs. 30 Lakhs for past two years (Govt./CPSU’s Laboratories, Research and

Development Laboratories, Laboratories run by Co-operative body and

Educational Institutions are exempted from the turnover criteria) however

turnover for the year 2012-13 should not be less than Rs. 30 lakhs, are eligible

to participate in the tender. Agents are not eligible to participate in the tender.

(b) Analytical Laboratory which has manufacturing activity of Drugs and

Medicines shall not be eligible to participate in the tender.

3. The complete set of tender document can be downloaded from the BPPI

website www.janaushadhi.gov.in and www.pharmaceuticals.gov.in free of

cost.

Submission of Tender Document:

4. The tenderer must submit the following documents in the sealed cover

superscribed Cover -‘A’ (all the documents have to be sealed and copies have

to be self attested and notarized in all pages).

[a]. The Earnest Money Deposit (EMD) shall be Rs.10,000/-( Rupees Ten

Thousand only) paid in the form of Demand Draft drawn in favour of

BUREAU OF PHARMA PUBLIC SECTOR UNDERTAKINGS OF

INDIA payable at Delhi/Gurgaon, should be sent with tender form in Cover-

6

‘A’. The EMD is refundable however it will not earn any interest. EMD in

the form of cheque/ cash/ postal order/ e-payment will not be accepted.

The EMD amount of unsuccessful bidder will be refunded to them within 30

days of finalization of tender. In respect of successful bidder (empanelled

bidder), the EMD amount will be adjusted towards security deposit.

[b]. Self attested and notarized Photocopies of Analytical Licence duly

renewed up to date, issued by the Drug Controller of the state and NABL

accreditation certificate.

[c]. Documentary evidence of having analyzed Drugs and medicines for the

last two years with the statement in the Proforma given in Annexure-I

[d]. Self attested and notarized photocopy of Certificate of Registration for

Service Tax should be enclosed in Annexure-II

[e]. Self attested and notarized document of the following should be furnished

in the format given in Annexure-III

(i). List of qualified personnel employed in the Laboratories along

with their experience and details of their approvals

(ii). The list of sophisticated instruments available in the Laboratory

7

(iii). Facilities available in Microbiological Section in the laboratory

[f]. A declaration in the Proforma given in Annexure-IV duly signed and

notarized.

[g]. Details of Drugs and medicines to be analyzed to be given in Annexure-V

[h]. Documentary evidence for the constitution of Labs viz. Memorandum

and Articles of Association, partnership deed etc, with details of name,

address, telephone no., fax no. e-mail address of Managing Director/ Partner/

Proprietor.

[i]. The instruments such as power of attorney, resolution of Board etc

authorizing the tenderer, should be enclosed in the tender (in Cover-‘A’) duly

signed by authorized signatory of the laboratory. Such Authorized Officer of

the tenderer should sign at the bottom of all the pages of the tender

documents.

5. Other Documents to be enclosed: [Self attested and notarized]

(i). Annual turnover statement certified by the auditors for last two years i.e.,

2011-12 and 2012-13.

(ii).The tenderer shall submit the checklist of documents in the enclosed

Proforma in Annexure –VI

8

Price Bid (Cover-‘B’)

6. (a). Price Bid (Annexure VII) of the tenderer duly filled in giving the rate

of testing, charges for complete testing of each sample and signed on each

page by Authorized person with company seal, should be sent in separate

sealed cover indicating name of the tenderer and superscribing “Price Bid”

Cover –‘B’ hereafter called Cover-‘B’.

(b). Cover-‘B’ shall contain the rates quoted by the tenderer only. It shall not

contain any other document. No condition shall be indicated in the Price Bid.

All the terms and conditions shall be indicated only in the Technical bid.

7.(a). The tender documents and certificates must be submitted in a separate

sealed cover as Cover-‘A’ and Price Bid shall be kept in separate sealed

cover as Cover-‘B’. Both Cover-‘A’ and Cover-‘B’ shall be kept in single

sealed cover on which it shall be superscribed as “TENDER FOR

EMPANELMENT OF ANALYTICAL TESTING LABORATORIES

FOR THE ANALYSIS OF DRUGS AND MEDICINES FOR TWO

YEARS FOR 2014-2015

9

(b). The tender document should reach General Manager, BPPI, IDPL

Corporate Office, IDPL Complex, Dundahera, Gurgaon-122016

(Haryana), till 06/01/2014 upto 15.00 hour.

(c). If the last date of submission is declared Holiday, the tenders may be

submitted on next working day upto 10.30 am.

(d).Tenderes should also enclose Soft Copy of Price Bid in CD along

with Cover-‘B’

General Conditions:

8. Forms in all Annexures should be filled up properly. Every correction

should invariably be attested by tenderer, failing which the tender will be

summarily rejected.

9. The tenderer should quote the rates for complete analysis for each drug and

medicine not for individual test to be performed.

10. The rates should be exclusive of taxes.

11. The rates quoted and accepted will be binding on the tenderer for

stipulated period and on no account any revision will be entertained till the

completion of the contract period.

10

12. The tender submitted by the laboratory which has been blacklisted by the

State / Central Govt. organization, shall not be considered.

ACCEPTANCE OF TENDER

13. Out of two covers submitted by each tenderer, Cover- ‘A’ will be opened

first at 15.30 hours on 06/01/2014 in the presence of tenderers or their

authorized representatives who chooses to be present. After scrutiny of the

documents and information furnished in Cover-‘A’ and confirmation of

details stated therein, a list of eligible laboratories will be shortlisted.

14. Cover-‘B’ (Price Bid) of the tenderers found eligible on the basis of

scrutiny of Cover-‘A’ will be opened subsequently and the date and time for

opening of Cover-‘B’ will be intimated to the shortlisted tenderers. The

acceptable rates for analysis will be decided on the basis of L1 rates and will

be communicated.

15. The tenderers other than L1 tenderer will be given opportunity to match

L1 rate and after due confirmation, their name/s will be included in the panel.

If required, the empanelled laboratories will be inspected by team of officials

of BPPI as and when need arises.

11

16. The tender inviting authority, BPPI reserves the right to accept or reject

any tender for any one or more of the items tendered for, without assigning

any reason.

17. No tenderer will be allowed to withdraw their bid after opening of Price

Bid.

AGREEMENT

18. All tenderer who are empanelled will have to execute an agreement on

non-judicial stamp paper of Rs. 100/-(stamp duty to be paid by tenderer) in

favour of BUREAU OF PHARMA PUBLIC SECTOR UNDERTAKINGS

OF INDIA within 15 days from the date of intimation received by them from

BPPI that their tenders have been accepted. The form of Agreement is

enclosed in tender document.

SECURITY DEPOSIT

19. The successful tenderers must pay a security deposit of Rs. 20,000/-

(Rupees Twenty Thousand only) including adjustment of EMD amount at the

time of execution of agreement referred in Para 18 above by way of DD in

favour of BUREAU OF PHARMA PUBLIC SECTOR UNDERTAKINGS

OF INDIA payable at Delhi/Gurgaon.

12

COMPLETE ANALYSIS AND REPORTING CONDITION

20. (a). On empanelment and entrustment of the job, the analytical laboratory

should furnish the test reports within,

(1). 8 days of receipt of sample in case of Tablet, Capsules, Ointment,

Cream, Gel, Powder and Liquid oral preparations.

(2). 21 days of receipt of sample in case of IV fluids and DPI (Dry

Powder Inject able)

(3). Within 24 hours of receipt of sample, the confirmation of receipt

should be given to BPPI by fax / mail.

(4). For any delay more than stipulated time in Para 20 (a)(1) and (2) as

the case may be, 1% of testing charges per week and the part thereof

would be deducted as penalty. If consecutively for 4 times or more

than 8 times in a year or a delay of more than 10 days occurs over the

time period stipulated above , then the penalty for subsequent delays

would be 2% of testing charges per week and part thereof.

13

(b). All the test mentioning IP, BP, USP should be carried out for each and

every sample. The results obtained in test should be mentioned in figures.

(c). “COMPLIES” or “PASSES” in result column of the report is treated as

incomplete report, if the result has some value.

(d). Every test report should have some specific remark as ‘Standard Quality’

or ‘Not of Standard Quality’.

(e). Report should have Sr.NO., Description of tests, specifications and results

obtained.

(f). Reports should be attached along with spectra or other data sheets, if

applicable.

(g). Report should be sent to General Manager (A and F), BPPI office as hard

copy and simultaneously scanned copy should be sent by e-mail

mahadevpharm.bppi@gmail.com.

21. All test report should be submitted to BPPI in duplicate. In case of failure

of sample, result should be communicated immediately to Manager

Regulatory BPPI through phone/ fax/ e-mail and physical report should be

sent with covering letter addressed to General Manager (A&F) at Bureau of

14

Pharma Public Sector Undertakings of India (BPPI), IDPL Corporate Office,

IDPL Complex, Dundahera, Gurgaon-122016 (Haryana).

22. If in any circumstances (like breakdown of instrument or non-availability

of reference standard etc.) the analytical laboratory is unable to undertake

sample, the same should be reported within 24 hours of receipt of such

sample by fax/ e-mail to Manager Regulatory and sample should be returned

to him immediately.

23. If any sample is received in damaged condition by the laboratory, the

sample should not be analyzed and should be sent back immediately to

Manager Regulatory, BPPI and due information should be given by fax/ e-

mail.

24. Manager Regulatory, BPPI or authorized representatives have the right to

inspect the laboratories of the tenderer who have submitted tenders before

taking any decisions regarding empanelment. He may also inspect any

laboratory which is empanelled at any time during continuance of tender and

initiate action to terminate / cancel its empanelment of not to entrust any

further testing job to the laboratory if any violation of tender conditions are

noticed during such inspections.

15

PAYMENT PROVISIONS

25. No advance payment towards any analysis will be made to tenderer.

26. No payment will be made for incomplete analysis or incomplete report.

Refer Para 20 (b) to 20 (g)

27. (a) Payments towards the analysis of Drugs and Medicines will be made

along with Tax at the prevailing rate as applicable at the time of payment

strictly as per rules

(b) The bills should be submitted along with the copy of test report.

Efforts will be made to make payments within 30 days from the date of

receipt of the bills by BPPI if same are found in order in all respect.

PENALTIES PROVISIONS

28. If the successful tenderer fails to execute the agreement and payment of

security deposit after opening of Price Bid within the specified time or

withdraws the tender after the intimation of acceptance of tender has been

received by them or owing to any other reasons, the tenderer is unable to

undertake the contract, the empanelment will be cancelled and security

deposit shall stand forfeited to BPPI. Such tenderer will also be liable for all

16

damages sustained by BPPI by reasons of breach of tender conditions. Such

damages shall be assessed by CEO, BPPI whose decision shall be final.

29. (a). Non performance of any tenderer or empanelment conditions will

disqualify a laboratory to participate in the next tender.

(b). To assess the correctness of the test results being given by the

empanelled laboratory, samples would also be taken and sent randomly

to Govt. laboratory/ CPSUs Laboratories which are not empanelled for

testing and if any variation is found, the result would be informed to

empanelled laboratory. If there is any variation in the analytical reports

furnished by empanelled laboratories, (either pass or fail) with Govt.

/CPSUs Laboratory, the empanelled laboratory will be blacklisted for

two years besides forfeiture of security deposit, after giving due

opportunity to the concerned laboratory.

30. If it is revealed that analytical laboratory is involved in any form of fraud

and collusion with the suppliers of BPPI, the analytical laboratory will be

black listed for five years. The tenderer shall also be liable for action under

criminal law and matter will be informed to drugs controller for penal action

against them.

17

31. The CEO, BPPI will be at liberty to terminate the empanelment without

assigning any reasons. The tenderer will not be entitled for any compensation

whatsoever in respect of such termination.

32. In all matters pertaining to tender, the decision of CEO, BPPI shall be

final and binding.

33. In event of any dispute arising out of tender, such dispute would be

subject to the jurisdiction of civil court within Delhi.

34. In case of dispute or difference arising between BPPI and empanelled

analytical laboratory relating to any matter arising out of or connected with

this tender agreement, such dispute or differences shall be settled in

accordance with the Arbitration and Conciliation Act 1996. The venue of

arbitration shall be Gurgaon.

18

Contract for Empanelment of Analytical Testing Laboratories

For the Analysis of Drugs and Medicines

AGREEMENT

Agreement made this ________ day of at BPPI Gurgaon between M/s

_______ having its registered office at ________ (hereafter referred to as ‘The

Laboratory’ which term should include its successors, representatives, hires,

executors, and administrators unless excluded by contract) on one part and

BPPI having its registered office at New Delhi on other part.

Whereas the Laboratory has agreed to undertake the analytical work to the

BPPI, the list of medicines mentioned in the Schedule attached hereto at the

rates noted therein and in the manner and under the terms and conditions

hereinafter mentioned.

And whereas the Laboratory has deposited with the BPPI a sum of Rs 20000/-

(Rupees Twenty thousand only) as Security Deposit for the due and faithful

performance of this Agreement, to be forfeited in the event of the Laboratory

failing duly and faithfully to perform it.

Now these presents witness that for carrying out the said Agreement in this

behalf into execution, The Laboratory and the BPPI do hereby mutually

19

convenient, declare, contract and agree each of them with the other of them in

the manner following, that is to say,

(1). The term “Agreement”, wherever used in this connection, shall mean and

include the terms and conditions in tender floated by the BPPI for

Empanelment of analytical testing, laboratories for the analysis of Drugs and

medicines for the year 2014-2015 the instructions to tenderer, the conditions

of tender, acceptance of tender particulars hereinafter defined and those

general and special conditions that may be added from time to time.

(2). (a). The Agreement is for undertaking analysis of drugs and medicines by

the Laboratory to the BPPI of the samples specified in the Schedule attached

hereto at the rates noted against each therein on the terms and conditions set

forth in the Agreement.

(b). This Agreement shall be deemed to have come into force with effect from

_______________ and it shall remain in force for a period upto date of

______________ and may however be extended for a further period, on

mutually agreed terms.

20

INSPECTION OF LABORATORY

(3). In respect of the analysis medicines in the Schedule, the Laboratory shall

allow inspection of the Laboratory at any time during the tender period by a

team of Experts/Officials whom the BPPI may depute for the purpose. The

Laboratory shall extend all facilities to the team to enable them to inspect

sample and Standard storage, Reagents, Instruments, all other records,

Analysis etc., in the Laboratory.

RECOVERY OF MONEY DUE TO BPPI FROM THE LABORATORY:

(4). All expenses, damages and other money payable to the BPPI by the

Laboratory under any provisions of this Agreement may be recovered from

the amount due or subsequently becoming due from the BPPI to the

Laboratory under this or any other Agreement. In case such amounts are

insufficient to fully cover such expenses, damages or other money payable, it

shall be lawful for the BPPI to recover the balance amount from the security

deposit of the Laboratory and all other money held by BPPI and in case such

Security Deposit is insufficient, then it shall also be lawful for the BPPI to

recover the residue of the said expenses, damages and moneys, if necessary,

by resorting to legal proceedings against the Laboratory.

21

AMOUNT OF SECURITY DEPOSIT TO BE MADE BY THE

LABORATORY:

(5). The Laboratory shall deposit with the BPPI equivalent to an amount of

testing charges for samples quoted by them, subject to minimum of

Rs.20,000/-. The amount of Security Deposit shall be remitted by the

Laboratory to the BPPI by way of Demand Draft favoring BUREAU OF

PHARMA PUBLIC SECTOR UNDERTAKINGS OF INDIA payable at

Delhi/Gurgaon. This agreement comes into effect only after the laboratory has

remitted the required amount of Security Deposit, not withstanding anything

contained in Para 2 (b) of this agreement.

SUBMISSION OF BILLS FOR UNDERTAKING ANALYSIS:

(6).(a). No advance payment towards any analysis will be made to the

Laboratory.

(b). All bills/invoices should be raised in duplicate in the name of General

Manager (A and F), BPPI. All payments shall be made by way of cheque

drawn in favour of Laboratory account and Crossed Account Payee / NEFT

only. The Laboratory shall furnish the details of their bank account no., name

22

of bank and branch, IFSC code No. etc to the BPPI. (An original cancelled

cheque leaf issued by their bank should be furnished).

ASSIGNMENT OF CONTRACT PROHIBITED:

(7). The Laboratory shall not, at any time, assign, sub-let or make over the

present contract or the benefits thereof or any part thereof, to any person or

persons whomsoever.

TERMINATION OF CONTRACT ON BREACH OF CONDITION:

(8). (a). In case the Laboratory fails or neglects or refuses to faithfully perform

any of the Covenants on his part herein contained or violets the condition in

the tender document, it shall be lawful for BPPI to forfeit the amount

deposited by the laboratory as security deposit and cancel the contract apart

from black listing the laboratory for period of two years.

(b). In case of laboratory fails or refuses to observe, perform fulfill and keep

all or any other or more or any part of anyone of covenants, stipulations and

provisions herein contain, it shall be lawful for BPPI on any such failure

neglect or refusal to put an end to this agreement and there upon every article

cause and thing herein contained on the part of BPPI shall cease and be void

and in case of any damage, loss, expense, differences in the cost or other

23

moneys than or any time during the continuance of this agreement becoming

due or owing by the laboratory to BPPI, it will be opened for BPPI to recover

from laboratory all such damages, losses, expenses, differences in cost nor

other moneys as aforesaid it shall be lawful for BPPI to appropriate the

security deposit made by laboratory as herein before mentioned to reimburse

all such damages, losses, expenses differences in cost and other moneys as

BPPI have sustained, incurred or put to by reason of the laboratory having

seen quality of any such failure, negligence or refusal as aforesaid or other

breach in the performance of contract.

(c). If at any time during the course of contract it is found that information by

the laboratory to BPPI, either in tender or otherwise, is false, BPPI may put an

end to contract / agreement wholly or in part and thereupon the provisions of

cause (a) shall apply.

(9). The BPPI reserves the right to terminate without assigning any reasons

therefore the contract/ agreement either wholly or in part without any notice

to the laboratory. The laboratory will not be entitled for any compensation

whatsoever in respect of such termination of contract by BPPI.

24

NOTICES ETC., IN WRITING

(10). All certificates or notices or orders for the time or for extra , varied or

altered laboratory, which are to be the subject of extra or varied charges

whether so described in the agreement or not, shall be in writing and unless in

writing shall not be valid, binding or be or any effect whatsoever.

LABORATORIES NOT TO HAVE ANY INTEREST IN THE

OFFICERS CONCERNED AND SUBORDINATED

(11). The laboratory shall not be in any way interested in or concerned directly

or indirectly with any of the officers, subordinates or servants of BPPI in

trade, business or transactions nor shall the laboratory give or pay or promise

to give or pay any such officer, subordinate or servant directly or indirectly

any money or fee or other consideration under designation of custom or

otherwise nor shall the laboratory permit any person or persons whomsoever

to interfere in the management or performance thereof under power of

attorney or otherwise without obtaining the consent of BPPI in writing.

BANKRUPTCY OF THE LABORATORY

(12). In case the laboratory at any time during the continuance of contact

becomes bankrupt or insolvent or commits any act of bankruptcy or

25

insolvency under the provisions of any law in that behalf for the time being in

force or should compound with his creditors, it shall be lawful for the BPPI to

put an end to the agreement, and there upon every article, para and thing

herein contend to be operative on the part of the BBPI, shall cease and be

void and the BPPI shall have the right and remedies given to him under the

president clauses.

SERVING OF NOTICES TO LABORATORY

(13). All notices or communications relating to or arising out this agreement or

any of the terms thereof shall be considered duly served on or given to the

laboratory if delivered to him or left at his premises, place of business or

above.

(14). And it is hereby agreed and declared between the parties hereto that in

case any question of dispute arises touching the construction or wording of

any Para herein contained on the rights, duties, liabilities of the parties hereto

or any other way, touching or arising out of the presents, the decision of CEO,

BPPI in the matter shall be final and binding.

(15). In the event of any disputes between the parties the dispute would be

subject to the jurisdiction of civil courts within Delhi only.

26

In witness where the laboratory and CEO acting for and on behalf of BPPI

have set their hands the day, month and year above written.

Authorized Signature of BPPI Authorized Signature of Laboratory

Name Name

Address and Seal Address and Seal

Witnesses for BPPI Witnesses for Laboratory

Signature Signature

Name Name

Address Address

27

ANNEXURE-I

Proforma for Performance Statement

(1). Name of Laboratory:

(2). Address:

(3). Performance Statement

Sr.

No.

Category No. of samples analyzed

during

Total no. of

Samples

2011-12 2012-13

1 Tablets

2 Capsules

3 LVP / SVP

4 Dry Powder

Injectables (DPI)

4 Liquid

Orals/Syrups

6 Ointments/

Creams/ Gel

7 Others

28

ANNEXURE-II

Details of Laboratory and Certificate of Registration for Service Tax

(1). Name of Laboratory

(2). Address of Head Office, if any:

(3). Address of Laboratory

(4). Name of contact person

(5). Phone No. :

Mobile No.:

(6). E-mail :

(7). Details of Licence issued by Drugs Regulatory Authority*

(8). Validity of Licence issued by Drugs Regulatory Authority:

(9). NABL Certificate No. along with discipline*

(10). Validity of NABL Certificate:

(11). Certificate of Registration for Service Tax: To be enclosed

(12). Any other certificates with details*

* enclose duly attested copy

29

ANNEXURE-III-A

Personnel in Laboratory

1) Total personnel engaged in Chemical / Instrumental analysis:

2) Total personnel engaged in Microbiological analysis:

3) Details of Competent (Approved) staff by State Licensing Authority

S.

No.

Name Designation Approval in Chemical /

Instrumental/

Microbiological Testing

Experience in

relevant

analysis (Years)

ANNEXURE-III-B

List of Sophisticated Instruments/ Apparatus in Laboratory

S. No. Name of

Instrument/

Apparatus

Make Date of Installation

Enclose additional paper

30

ANNEXURE-III-C

Facilities in Microbiological Section in Laboratory

1) List of cultures available: To be given

2) Details of equipments (e.g. Incubators, Laminar Air Flow etc.)

S. No. Name of

Instrument/

Apparatus

Make Date of Installation

Enclose additional paper

31

ANNEXURE-IV

Declaration Form (To be attested by Notary)

I / We _(Name of Bidder)_____________________________ having our

Head Office at ____________________ and Laboratory at

____________________ do declare that I / we carefully read all the

conditions of the tender of Bureau of Pharma Public Sector Undertakings of

India (BPPI), Gurgaon for empanelment of Analytical Testing Laboratories

for analysis of Drugs and Medicines for period 2014-2015 and abide by all

conditions said for therein.

I/We further declare that we have valid licence issued by Drug Regulatory

Authority bearing no. ____________ and NABL Certificate bearing no.

_________ in discipline ________.

Signature

Name of Authorized Person

Seal of Laboratory

32

Annexure – V

List of 361 Drugs and Medicines

BUREAU OF PHARMA PUBLIC SECTOR UNDERTAKINGS OF INDIA, GURGAON 122016

Tender for Empanelment of Analytical Testing Laboratories for the Analysis of Drugs and Medicines for the Year 2014-2015

Sl. No

Drug Code

Generic Name of the Medicines Unit Size Quoted by laboratory

As symbol (√)

Or yes

ANALGESIC/ ANTI-INFLAMMATORY/ MUSCLOSKELETAL DISORDER

1 1 Aceclofenac 100 mg + Paracetamol 500mg Tablets 10x10

2 2 Aceclofenac Tablets I.P. strength 100 mg 10x10

3 3 Aceclofenac Gel 3%w/w 30 g tubes

4 4 Acetaminophen 325 mg + Tramadol Hydrochloride

37.5 mg Tablets film coated

10x10

5 5 Asprin Tablets I.P. strength 150 mg 14x10 6 6 Chlorzoxazone 500 mg + Diclofenac 50 mg +

Paracetamol 500 mg Tablets film coated

10x10

7 7 Diclofenac Gel

Diclofenac Diethylamine 1.16%w/w equiv. to diclofenac sodium 1%w/w

15 g

8 8 Diclofenac Sodium 50mg + Serratiopeptidase 10mg Tablets

10x10

9 9 Diclofenac Sodium (SR) 100 mg Tablets 10x10

10 10 Diclofenac Sodium Injection I.P. strength 25mg/ml 3 ml

11 11 Diclofenac Sodium Tablets I.P. strength 50mg 10x10 12 12 Etoricoxilb Tablets strength 120mg 10x10 13 13 Etoricoxilb Tablets 90mg 10x10

14 14 Ibuprofen 400 mg+ Paracetamol 325 mg Tablets 10x10 15 15 Ibuprofen Tablets I.P. film coated strength 200mg 10x10 16 16 Ibuprofen Tablets I.P. film coated strength 400 mg 10x10 17 17 Indomethacin Capsulesules I.P. strength 25 mg 10x10

18 18 Methyl Salicylate Oint. (Eutheria) Methyl Salicylate I.P. 11.25%w/v

Menthol I.P. 4.7%w/v

Eucalyptol I.P. 7.2%v/w

20 g

19 19 Nimesulide 100 mg+ Paracetamol 500mg Tablets 10x10 20 20 Nimesulide Tablets BP strength 100 mg 10x10

21 21 Paracetamol 325mg + Diclofenac Sodium 50 mg

Tablets

10x10

33

22 22 Paracetamol Syrup I.P. strength 125 mg /5 ml 60 ml

bottles

23 23 Paracetamol Tablets I.P. strength 500mg 10x10

24 24 Pentazocine Injection I.P. strength 30 mg/ ml 1 ml

25 25 Serratiopeptidase Tablets I.P. strength 10 mg 10x10

26 26 Tramadol Injection 100 mg 2ml

27 27 Tramadol Injection 50 mg 1ml

28 28 Tramadol Tablets 50 mg 10x10

ANTIBIOTICS

29 29 Acyclovir Tablets I.P. film coated strength 400 mg 10x10

30 30 Amikacin Injection I.P. strength 100mg Vial

31 31 Amikacin Injection I.P. strength 250mg Vial

32 32 Amikacin Injection I.P. strength 500mg Vial

33 33 Amoxycillin 250 mg + Bromhexine 8 mg Capsules 10x10

34 34 Amoxycillin 500 mg + Bromhexine 8 mg Capsules 10x10

35 35 Amoxycillin I.P. 1000 mg + Clavulanic acid I.P.

200mg Injection

Vial with

WFI

36 36 Amoxycillin I.P. 200 mg + Clavulanic acid 28.5 mg

/5ml Dry Syrup I.P.

30 ml

bottles

37 37 Amoxycillin I.P. 250 mg + Clavulanic acid I.P. 50 mg Injection

Vial with WFI

38 38 Amoxycillin I.P. 500 mg + Clavulanic acid I.P. 100mg

Injection

Vial with

WFI

39 39 Amoxycillin I.P. 500 mg + Clavulanic acid I.P. 125

mg Tablets film coated

6x10

40 40 Amoxycillin 250 mg+ Cloxacillin 250 mg Capsules 10x10

41 41 Amoxycillin 250 mg + Dicloxacillin 250 mg Capsules 10x10

42 42 Amoxycillin Kid Tablets I.P. strength 125 mg 10x10

43 43 Amoxycillin Dry Syrup I.P. strength 125mg/ 5ml 60 ml bottles

44 44 Amoxycillin Capsulesules I.P. strength 250 mg 10x10

34

45 45 Amoxycillin Capsulesules I.P. strength 500 mg 10x10

46 46 Ampicillin Injection I.P. strength 500mg Vial

47 47 Azithromycin Syrup I.P. strength 100mg/ 5ml 15 ml

bottles

48 48 Azithromycin Tablets DT strength 100 mg 10x10

49 49 Azithromycin Tablets I.P. film coated strength 250 mg

10x10

50 50 Azithromycin Tablets I.P. film coated strength 500

mg

10x10

51 51 Cefadroxil Tablets I.P. film coated strength 250 mg 10x10

52 52 Cefadroxil Tablets I.P. film coated strength 500 mg 10x10

53 53 Cefixime Dry Syrup I.P. strength 50 mg/ 5ml 30 ml

bottles

54 54 Cefixime Tablets I.P. film coated strength 100mg 10x10

55 55 Cefixime Tablets I.P. film coated strength 200mg 10x10

56 56 Cefoperazone 1g + Sulbactam 1g Injection Vial & WFI

57 57 Cefoperazone 500 mg + Sulbactam 500 mg Injection Vial & WFI

58 58 Cefoperazone Injection I.P. strength 1 gm Vial

59 59 Cefotaxime Sodium 1g + Sulbactam Sodium 500 mg

Injection

Vial & WFI

60 60 Cefotaxime Sodium 250 mg + Sulbactam Sodium 125

mg Injection

Vial & WFI

61 61 Cefotaxime Sodium 500 mg + Sulbactam Sodium 250 mg Injection

Vial & WFI

62 62 Cefotaxime Sodium Injection I.P. strength 1000mg Vial & WFI

63 63 Cefotaxime Sodium Injection I.P. strength 250 mg Vial & WFI

64 64 Cefotaxime Sodium Injection I.P. strength 500 mg Vial & WFI

65 65 Cefpodoxime Tablets DT strength 100 mg 10x10

66 66 Cefpodoxime Tablets I.P. film coated strength 200

mg

10x10

67 67 Ceftazadime Injection I.P. strength 1000 mg Vial & WFI

68 68 Ceftazadime Injection I.P. strength 250 mg Vial & WFI

35

69 69 Ceftazadime Injection I.P. strength 500 mg Vial & WFI

70 70 Ceftriaxone 1000 mg + Sulbactam 500 mg Injection Vial & WFI

71 71 Ceftriaxone 1000 mg + Tazobactum 125 mg

Injection Vial & WFI

72 72 Ceftriaxone 250 mg + Tazobactum 31.25 mg

Injection Vial & WFI

73 73 Ceftriaxone 250 mg +Sulbactam 125 mg Vial & WFI

74 74 Ceftriaxone 500 mg + Sulbactam 250 mg Vial & WFI

75 75 Ceftriaxone Injection I.P. strength 1 g Vial & WFI

76 76 Ceftriaxone Injection I.P. strength 250 mg Vial & WFI

77 77 Ceftriaxone Injection I.P. strength 500 mg Vial & WFI

78 78 Cefuroxime Axetil Tablets I.P. film coated strength

250 mg

10x10

79 79 Cefuroxime Axetil Tablets I.P. film coated strength 500mg

10x10

80 80 Cephalexin Tablets DT strength 125 mg 10x10

81 81 Cephalexin Capsulesules I.P. strength 250 mg 10x10

82 82 Cephalexin Capsulesules I.P. strength 500 mg 10x10

83 83 Ciprofloxacin 250 mg + Tinidazole 300 mg Tablets

film coated

10x10

84 84 Ciprofloxacin 500 mg + Tinidazole 600 mg Tablets

film coated

10x10

85 85 Ciprofloxacin Tablets I.P. film coated strength 250 mg

10x10

86 86 Ciprofloxacin Tablets I.P. film coated strength 500

mg

10x10

87 87 Clotrimazole Ointment I.P. strength 1% w/w 15 g tubes

88 88 Co-trimoxazole Suspension I.P. strength Sulphamethoxazole 200mg + Trimethoprim

40mg / 5ml

50 ml bottle

89 89 Co-trimoxazole Tablets I.P. (Double Strength)

strength Sulphamethoxazole 800 mg +

Trimethoprim 160mg

10x10

90 90 Co-trimoxazole Pead. Tablets I.P.

strength Sulphamethoxazole 100 mg + Trimethoprim 20mg

10x10

36

91 91 Co-trimoxazole Tablets I.P.

(Single Strength) strength Sulphamethoxazole 400 mg +

Trimethoprim 80mg

10x10

92 92 Doxycycline Capsulesules I.P. strength 100 mg 10x10

93 93 Erythromycin Stearate Tablets I.P. film coated strength 250 mg

10x10

94 94 Gentamycin Sulphate Injection I.P. strength 80 mg/ 2ml

2 ml

95 95 Levofloxacin Tablets I.P. film coated strength 250 mg 10x10

96 96 Levofloxacin Tablets I.P. film coated strength 500 mg

10x10

97 97 Meropenem Injection I.P. strength 1gm Vial & WFI

98 98 Norfloxacin 400 mg + Tinidazole 600 mg Tablets film

coated

10x10

99 99 Norfloxacin Tablets I.P. film coated strength 400 mg 10x10

100 100 Ofloxacin 200 mg + Ornidazole 500 mg Tablets film coated

10x10

101 101 Ofloxacin Tablets I.P. film coated strength 200 mg 10x10

102 102 Ofloxacin Tablets I.P. film coated strength 400 mg 10x10

103 103 Piperacillin 4 g + Tazobactum 0.5 mg Injection Vial & WFI

104 104 Roxithromycin Suspension strength 50 mg/ 5ml 30 ml

bottles

105 105 Roxithromycin Tablets I.P. film coated strength 150 mg

10x10

106 106 Roxithromycin Tablets I.P. film coated strength 300 mg

10x10

107 107 Tinidazole Tablets I.P. film coated strength 300 mg 10x10

108 108 Tinidazole Tablets I.P. film coated strength 500 mg 10x10

109 109 Vancomycin I.P. strength 500 mg Vial & WFI

ANTI INFECTIVES (TOPICALS)/ ANTIFUNGAL/

SKIN OINTMENT

110 110 Adapalene 0.1 % w/v Ointment 15 g tubes

111 111 Application Benzyl Benzoate Lotion I.P. strength 25 % w/w

100 ml

112 112 Beclomethasone 0.025%w/w + Clotrimazole 1.0% +

Gentamycin 0.1% w/w Cream

15 g tubes

37

113 113 Beclomethasone 0.025% w/w + Neomycin 0.5%

w/w Cream

15 g tubes

114 114 Beclomethasone Dipropionate Oint. I.P. strength 0.025% w/v

15 g tubes

115 115 Calamine Lotion I.P. 100 ml

bottles

116 116 Chlorhexidine Gluconate Solution I.P. strength 5% 500 ml

bottles

117 117 Chlorhexidine Gluconate 0.2% Mouth Wash 150 ml bottles

118 118 Clobetasol Propionate Cream strength 0.05 % w/w 15 g tubes

119 119 Fluconazole Tablets I.P. film coated strength 150 mg 10x10

120 120 Fusidic Acid Cream strength 2 % w/v 10 g tubes

121 121 Glutaraldehyde Solution strength 2% w/v 500 ml

bottles

122 122 Ketoconazole Lotion strength 2 % w/w 100 ml

bottles

123 123 Lignocaine Ointment strength 2% w/w 30 g tubes

124 124 Povidone Iodine Ointment strength 5% w/w 250 gm

tubes

125 125 Povidone Iodine Ointment strength 5% w/w 15 gm

tubes

126 126 Povidone Iodine Solution I.P. strength 10 % 500 ml bottles

127 127 Povidone Iodine Solution I.P. strength 5 % 100 ml

bottles

128 128 Povidone Iodine Solution I.P. strength 5 % 500 ml

bottles

129 129 Povidone Iodine Solution I.P. strength 7.5% 500 ml bottles

130 130 Solution Antiseptic

Chlorhexidine 1.5%w/v + Cetramide 3%w/v

Solution

100 ml

bottles

131 131 Silver Sulphadiazine Cream strength 1 % w/w 20 gm tubes

132 132 Silver Sulphadiazine Cream strength 1 % w/w 500 gm

jars

ANTIDIABETIC DRUGS

133 133 Glibenclamide Tablets (Scored Oval) I.P. strength

2.5 mg

10x10

134 134 Glibenclamide Tablets (Scored Oval) I.P. strength 5

mg

10x10

135 135 Gliclazide Tablets I.P. strength 40 mg 10x10

38

136 136 Gliclazide Tablets I.P. strength 80 mg 10x10

137 137 Glimeperide Tablets I.P. strength 1mg 10x10

138 138 Glimeperide Tablets I.P. strength 2mg 10x10

139 139 Glimeperide 1mg + Metformin 500mg + Pioglitazone

15mg

10x10

140 140 Glimeperide 2mg + Metformin 500mg + Pioglitazone 15mg

10x10

141 141 Glipizide 5 mg Tablets I.P. strength 10x10

142 142 Insulin Injection (Human) I.P. strength 40iu/ml 10 ml Vial

143 143 Insulin Injection {Insulin Human (Soluble 30% & Isophane 70%) 40iu/ml}

10 ml Vial

144 144 Metformin Hydrochloride SR Tablets I.P. strength

1000 mg

10x10

145 145 Metformin Hydrochloride Tablets I.P. strength

500mg

10x10

146 146 Pioglitazone Tablets I.P. strength 15 mg 10x10

147 147 Pioglitazone Tablets I.P. strength 30 mg 10x10

148 148 Pioglitazone 15 mg Tablets + Glimeperide 1mg 10x10

149 149 Pioglitazone 15 mg Tablets + Glimeperide 2mg 10x10

150 150 Pioglitazone 15 mg Tablets + Metformin 500mg 10x10

ANTI-MIGRAINE DRUGS

151 151 Dihydroergotamine Tablets film coated strength 1 mg

10x10

ANTI-NEOPLASTIC DRUGS

152 152 Bleomycin Injection I.P. strength 15 mg Vial

153 153 Cisplatin Injection 10 mg Vial

154 154 Cisplatin Injection I.P. strength 50 mg Vial

155 155 Doxorubicin Injection I.P. strength 10 mg Vial

156 156 Doxorubicin Injection I.P. strength 50 mg Vial

157 157 Etoposide Capsulesules I.P. strength 100 mg 10x10

39

158 158 Etoposide Injection I.P. strength 100 mg/5ml Vial

159 159 Gemcitabine Injection strength 1000 mg Vial

160 160 Gemcitabine Injection strength 200 mg Vial

161 161 Medroxyprogestrone Acetate Tablets film coated 10

mg

10x10

162 162 Raloxifene Tablets strength 60 mg 10x10

163 163 Tamoxifen Citrate Tablets I.P. strength 10 mg 10x10

164 164 Tamoxifen Citrate Tablets I.P. strength 20 mg 10x10

I. V. FLUIDS

165 165 Ciprofloxacin Infusion I.P. strength 2mg/ml 100 ml

bottles

166 166 Dextrose (10D) I.P. strength 10% 500 ml

bottles

167 167 Dextrose (5 D) I.P. strength 5% 500 ml

168 168 Glucose Normal Saline (DNS) Dextrose 5%w/v,

sodium chloride 0.9%w/v

500 ml

bottles

169 169 Levofloxacin Infusion I.P. strength 500 mg 100 ml

bottles

170 170 Mannitol I.P. strength 20% 100 ml bottles

171 171 Mannitol I.P. strength 20% 350 ml

172 172 Metronidazole Infusion I.P. strength 5 mg /ml 100 ml

173 173 Normal Saline (NS) I.P. strength 0.9%w/v 500 ml

174 174 Plasma Volume Expander (Gelatin Base) 500 ml

175 175 Ringer Lactate (RL) I.P. strength 10% infusion 500 ml

176 176 Water for Injection I.P. 5ml Amp

GASTROINTESTINAL TRACT/ ANTHELMINTICS

177 177 Albendazole Syrup Strength 200 mg/ 5ml 10 ml

bottles

178 178 Albendazole 400 mg + Ivermectin 6mg Tablets 10x1 Tablets

179 179 Albendazole Tablets I.P. strength 400mg 10x10

40

180 180 Bisacodyl Tablets I.P. strength 5mg 10x10

181 181 Cyproheptadine HCl 2 mg + Tricholine Citrate 275 mg Syrup

200 ml bottles

182 182 Dicyclomine 20 mg + Mefenamic Acid 250 mg

Tablets

10x10

183 183 Dicyclomine Tablets I.P. strength 10 mg 10x10

184 184 Dicyclomine HCl. & Paracetamol Tablets strength Dicyclomine HCl 20 mg

Paracetamol 325 mg

10x10

185 185 Diethylcarbamazine citrate Tablets I.P. film coated strength 100 mg

10x10

186 186 Domperidone Tablets I.P. strength 10 mg 10x10

187 187 Domperidone 5 mg. / 5 ml Syrup 30 ml

bottles

188 188 Dried Aluminum hydroxide 250mg + Magnesium Hydroxide 250mg + Simethicone 50mg Tablets

10x10

189 189 Enzyme Syrup Diastase(1:1200) 50mg

Pepsin (1:3000) 10mg per 5ml

200 ml bottles

190 190 Enzyme Tablets film coated 10x10

191 191 Famotidine Tablets I.P. strength 20 mg 10x10

192 192 Famotidine Tablets I.P. strength 40 mg 10x10

193 193 Furazolidone Tablets I.P. strength 100 mg 10x10

194 194 Hyoscine Butyl Bromide Tablets I.P. film coated

strength 10 mg

10x10

195 195 Ispagula Husk Powder I.P. 200 g

Pack

196 196 Lactobacillus 60 million spores Tablets 10x10

197 197 Lactulose Syrup strenth 10 g/15 ml 100 ml

bottles

198 198 Aluminium Hydroxide 250mg + Magnesium

Hydroxide 250mg / 5ml Suspension

170 ml

199 199 Metoclopramide Tablets I.P. strength 10 mg 10x10

200 200 Metoclopramide Injection I.P. strength 5mg/ml 2 ml

201 201 Metronidazole Tablets I.P. film coated strength 200

mg

10x10

202 202 Metronidazole Tablets I.P. film coated strength 400 mg

10x10

41

203 203 Misoprostol Tablets film coated 200 mcg 4x10

204 204 Norfloxacin 100 mg + Metronidazole 100 mg/5 ml Syrup

30 ml bottles

205 205 Ofloxacin 50 mg + Metronidazole 100mg/5 ml Syrup 30 ml

bottles

206 206 Omeprazole 20 mg + Domperidone 10 mg Capsules 10x10

207 207 Omeprazole Tablets film coated strenght 20 mg 10x10

208 208 Ondansetron Injection I.P. strength 2 mg/ml 2 ml

209 209 Ondansetron Tablets I.P. strength 4 mg 10x10

210 210 Ornidazole Tablets I.P. film coated strength 500 mg 10x10

211 211 Pantoprazole Tablets I.P. film coated strength 20 mg 10x10

212 212 Pantoprazole Tablets I.P. film coated strength 40 mg 10x10

213 213 Pantoprazolel Injection I.P. strength 40 mg/ 10m Vial

214 214 Rabeprazole 20 mg + Domperidone 30 mg Tablets

SR

10x10

215 215 Rabeprazole Tablets I.P. film coated strength 20 mg 10x10

216 216 Ranitidine Injection I.P. strength 50 mg/ 2ml 2ml

217 217 Ranitidine HCl Tablets I.P. film coated strength 150

mg

10x10

218 218 Ranitidine HCl Tablets I.P. film coated strength 300

mg

10x10

VITAMINS

219 219 Calcium carbonate 1250mg + Vitamin D3 250iu

Tablets film coated

10x10

220 220 Calcium carbonate 1250mg + Vitamin D3 500iu

Tablets film coated

10x10

221 221 Calcium Citrate 100 mg + Vitamin D3 125 iu Syrup 150 ml

bottles

222 222 Calcium with Minerals Suspension 150ml

223 223 Doxyalamine Succinate 10 mg + Pyridoxine 10 mg +

Folic Acid 2.5 mg Tablets film coated

10x10

224 224 Folic Acid Tablets I.P. strength 5mg 10x10

225 225 Iron + Folic Acid Syrup Ferrous Fumerate equivalent to elemental Iron 20mg, Folic

Acid 100 mcg per ml

200 ml bottles

42

226 226 Iron, Folic Acid & Zinc (Carbonil Iron) Capsules 15 x10

227 227 Polyvitamin (Prophylactic) NFI Tablets film coated 10x10

228 228 Tonic Iron, Folic Acid & Zinc (Carbonil Iron) Syrup 200 ml

bottles

229 229 Vitamin + Iron Tonic Syrup 100 ml

bottles

230 230 Vitamin B Complex with Vitamin C & Zinc (Cebexin -Z) Capsules

10x10

231 231 Vitamin B-Complex (Prophylactic) film coated

Tablets

10x10

232 232 Vitamin B-Complex NFI Syrup 200 ml

bottles

233 233 Vitamin-C Chewable Tablets I.P. strength 500mg 10x10

RESPIRATORY SYSTEM & ANTI-ALLERGICS

234 234 Budesonide Respule strength 0.25 mg/ml 2 ml

235 235 Budesonide Respule strength 0.5 mg/ml 2 ml

236 236 Budesonide 100 mcg/dose 30

Rotacaps

237 237 Budesonide 200 mcg 30

Rotacaps

238 238 Budesonide Inhaler strength 200 mcg/dose 200 md

239 239 Cetrizine Syrup I.P. strength 5mg/ 5ml 60 ml

bottles

240 240 Cetrizine Tablets I.P. film coated strength 10mg 10x10

241 241 Cough Syrup (Dextromethorphan Based) Syrup 100 ml bottles

242 242 Cough Syrup

Chlorpheniramine Maleate I.P. 3 mg + Ammonium

Chloride I.P. 110 mg + Sodium Citrate I.P. 46mg + Menthol I.P. 0.9mg

+Chloroform I.P. 0.5%w/v

110ml

bottles

243 243 Cough Syrup

Diphenhydramine 14mg + Ammonium Chloride I.P. 135mg + Sodium Citrate I.P. 57mg + Menthol I.P.

0.9mg

110ml

bottles

244 244 Etophyllin 84.7 mg + Theophylline 25.3 mg Injection 2 ml

245 245 Etophyllin 77 mg +Theophylline 23 mg Tablets 10x10

246 246 Fexofenadine Tablets I.P. film coated strength 120

mg

10x10

43

247 247 Fexofenadine Tablets I.P. film coated strength 180

mg

10x10

248 248 Levocetrizine Tablets I.P. film coated strength 5 mg 10x10

249 249 Levocetrizine HCl 5 mg + Pseudoephedrine 20 mg +

Paracetamol 325mg Tablets

10x10

250 250 Montelukast Sodium Tablets I.P. strength 5 mg 10x10

251 251 Montelukast Sodium Tablets I.P. strength 10 mg 10x10

252 252 Montelukast Sodium 10 mg + Levocetrizine 5mg

Tablets film coated

10x10

253 253 Pheniramine Maleate Tablets I.P. strength 25 mg 10x10

254 254 Promethazine Syrup I.P. strength 5 mg/ 5ml 100ml bottles

255 255 Salbutamol Inhaler I.P. strength 100 mcg/puff 200 md

256 256 Salbutamol Tablets I.P. strength 2 mg 10x10

257 257 Salbutamol Respule strength 2.5 mg 2.5 ml

258 258 Salbutamol 200 mcg 30

Rotacaps

259 259 Salbutamol Syrup I.P. strength 2mg /5ml 100 ml

bottles

260 260 Salbutamol Tablets I.P. strength 4 mg 10x10

CARDIOVASCULAR DRUGS/

DIURETICS/HYPOLIPIDAEMIC AGENT/ANTI-

COAGULANT

261 261 Adenosine 6 mg/ 2ml Amp. 2 ml

262 262 Amiodarone Tablets I.P. strength 100 mg 10x10

263 263 Amlodipine 5 mg + Atenolol 50 mg Tablets film coated

10x10

264 264 Amlodipine Tablets I.P. film coated strength 5mg 10x10

265 265 Atenolol Tablets I.P. strength 50 mg 14x10

266 266 Atorvastatin film coated Tablets I.P. strength 10mg 10x10

267 267 Atorvastatin Tablets film coated strength 20 mg 10x10

268 268 Clonidine Tablets I.P. strength 0.1 mg 10x10

269 269 Clopidogrel Tablets I.P. strength 75mg 10x10

44

270 270 Clopidogrel 75mg Tablets + Aspirin 75 mg 10x10

271 271 Diltiazem Tablets I.P. strength 30 mg 10x10

272 272 Diltiazem Tablets I.P. strength 60 mg 10x10

273 273 Dobutamine Injection strength 250 mg/ 20ml Vial

274 274 Dopamine HCl Injection strength 200 mg/5ml 5 ml

275 275 Enalpril Tablets I.P. strength 5mg 10x10

276 276 Enoxaparin Injection I.P. strength 40mg/0.4ml 0.4 ml

277 277 Enoxaparin Injection I.P. strength 60 mg/0.6 ml 0.6 ml

278 278 Frusemide Injection I.P. strength 10 mg/ml 2ml

279 279 Frusemide Tablets I.P. strength 40 mg 10x10

280 280 Heparin Sodium Injection I.P. strength 1000iu/ml

5 ml

281 281 Heparin Sodium Injection I.P. strength 5000iu/ ml 5 ml

282 282 Hydrochlorothiazide Tablets I.P. strength 12.5 mg 10x10

283 283 Isosorbide Dinitrate Tablets I.P. strength 10 mg 10x10

284 284 Isosorbide Mononitrate Tablets I.P. strength 10 mg 10x10

285 285 Lisinopril 5 mg + Amlodipine 5mg Tablets 10x10

286 286 Lisinopril Tablets I.P. strength 5mg 10x10

287 287 Losartan I.P. 50 mg & Hydrochlothaizide I.P. 12.5mg

Tablets film coated

10x10

288 288 Losartan film coated Tablets I.P. strength 25mg 10x10

289 289 Losartan PotassiumTablets I.P. film coated strength 50 mg

10x10

290 290 Metoprolol Tablets I.P. strength 25 mg 10x10

291 291 Metoprolol Tablets I.P. strength 50 mg 10x10

292 292 Nifedipine Capsulesules I.P. strength 10 mg 10x10

293 293 Ramipril Tablets I.P. strength 2.5 mg 10x10

45

294 294 Ramipril Tablets I.P. strength 5 mg 10x10

295 295 Simvastatin Tablets I.P. strength 10 mg 10x10

296 296 Simvastatin Tablets I.P. strength 20 mg 10x10

297 297 Tamsulosin Hydrochloride 0.4 mg Capsules 10x10

298 298 Telmisartan 40 mg + Hydrochlorthiazide 12.5 mg Tablets

10x10

299 299 Telmisartan Tablets I.P. strength 20 mg 10x10

300 300 Telmisartan Tablets I.P. strength 40 mg 10x10

301 301 Tranexamic Acid Tablets strength 500 mg 10x10

302 302 Tranexamic Acid Injection strength 500 mg/5ml 5 ml Amp.

ANTIMALARIAL DRUGS

303 303 Artesunate Tablets strength 50mg 10x10

304 304 Arteether Injection I.P. strength 150mg 2ml Vial

305 305 Chloroquine Phosphate Tablets I.P. film coated

strength 250 mg

10x10

306 306 Primaquine Tablets I.P. film coated strength 15 mg 10x10

307 307 Primaquine Tablets I.P. film coated strength 2.5 mg 10x10

308 308 Primaquine Tablets film coated 5 mg 10x10

309 309 Sulphadoxine 250 mg + Pyrimethamine 12.5 mg/5ml Syrup

10 ml bottles

310 310 Sulphadoxine I.P. 500 mg + Pyrimethamine I.P. 25

mg Tablets

(2X5X10)

ELECTROLYTES

311 311 Disodium hydrogen Citrate (Alkalyser) 1.4 mg/5ml Syrup

100 ml bottles

312 312 Oral Rehydration Salts Citrate IP (WHO Formula)

Sachet I.P. strength 21 GM

1S

CNS DRUGS/ANTI-EPILEPTIC DRUGS

313 313 Alprazolam film coated Tablets I.P. strength 0.25 mg 10x10

314 314 Alprazolam film coated Tablets I.P. strength 0.5 mg 10x10

46

315 315 Betahistine Tablets I.P. strength 16 mg 10x10

316 316 Betahistine Tablets I.P. strength 8 mg 10x10

317 317 Carbamazepine Tablets I.P. strength 100mg 10x10

318 318 Carbamazepine Tablets I.P. strength 200mg 10x10

319 319 Clonazepam Tablets I.P. strength 0.5 mg 10x10

320 320 Diazepam Tablets I.P. strength 5 mg 10x10

321 321 Escitalopram Tablets I.P. strength 10 mg 10x10

322 322 Escitalopram Tablets I.P. strength 20 mg 10x10

323 323 Flunarzine Tablets strength 10mg 10x10

324 324 Flunarzine Tablets strength 5mg 10x10

325 325 Fluoxetine hydrochloride Capsulesules I.P. strength 20 mg

10x10

326 326 Methyl Ergometrine Tablets I.P. strength 0.125mg 10x10

327 327 Phenytoin Sodium Tablets I.P. strength 100 mg 10x10

328 328 Prochlorperazine Tablets I.P. strength 5 mg 10x10

CORTICO – STEROIDS/DRUG USED IN

HYPOTHYRIODISM

329 329 Prednisolone Tablets I.P. strength 5 mg 10x10

330 330 Prednisolone Tablets I.P. strength 10 mg 10x10

331 331 Thyroxine Sodium Tablets I.P. strength 50 mcg 10x10

332 332 Thyroxine Sodium Tablets I.P. strength 100 mcg 10x10

333 333 Dexamethasone Tablets I.P. strength 0.5 mg 10x10

334 334 Dexamethasone Injection I.P. strength 40 mg 2 ml

DIETARY SUPPLEMENT

47

335 335 Protein Powder Protein

hydrolysate 16.8g vit A 1600iu, C 25mg, B1 1mg, B2-1.37mg, B6-0.5mg, B12-0.5mcg, E 5iu, D3-100iu,

B3-0.13mg, malt ext. 4.8g, d-penthol 1mg, cal. Phos. 0.4g, pot. 0.13mg, folic acid 50mcg, choline bitart

0.15g ferrous gluconate 17mg, per 30gm

200 g Jar

DRUGS USED IN GOUT

336 336 Allopurinol Tablets I.P. strength 100 mg 10x10

HORMONES AND RELATED DRUGS

337 337 Clomiphene citrate Tablets I.P. strength 50 mg 10x10

OPHTHALMIC PREPARATION

338 338 Atropine Sulphate Injection I.P. strength 0.6mg/ ml 1ml

339 339 Betaxolol Hydrochloride 0.5 % w/w Eye Drop 5 ml

340 340 Acyclovir 3% w/w Eye Onit. 5 g

341 341 Carboxymethyl Cellulose 0.5 % w/v Eye Drop 10 ml

342 342 Chloramphenicol Eye Drop I.P. strength 1 % w/v 5 ml

343 343 Chloramphenicol Eye Applicaps I.P. strength 1 % w/v 100

Applicaps

344 344 Ciprofloxacin Eye Drop I.P. strength 0.3% w/v 5 ml

345 345 Gentamycin Eye Drop I.P. strength 0.3% w/v 5 ml

346 346 Ketorolac Tromethamine Eye Drop 0.5 % w/v 5 ml

347 347 Prednisolone Acetate 1 % w/v Eye Drop 5 ml

348 348 Sulphacetamide Sodium Eye Drop I.P. strength 10 % w/v

10 ml

349 349 Sulphacetamide Sodium Eye Drop I.P. strength 20 %

w/v

10 ml

350 350 Timolol Maleate Eye Drop I.P. strength 0.5 % w/v 5 ml

OROPHARYNGEAL

351 351 Xylometazoline Nasal Drop I.P. strength 0.1 % w/v 10 ml

SURGICAL ANESTHETICS

48

352 352 Bupivacaine Hydrochloride Injection I.P. strength

0.5% w/w

4 ml X 5

353 353 Ketamine Hydrochloride Injection I.P. strength 10 mg/ml

10 ml

354 354 Ketamine Hydrochloride Injection I.P. strength 50

mg/ml

2 ml

355 355 Lignocaine Injection I.P. strength 1% w/v 20 ml Vial

356 356 Lignocaine Injection I.P. strength 2% w/v 20 ml Vial

357 357 Lignocaine I.P. 1% + Adrenaline I.P. 2% w/v

Injection

30 ml Vial

358 358 Propofol Injection I.P. strength 10 mg/ml 10ml Vial

VACCINES

359 359 Tetanus Toxoid Injection 0.5 ml

Amp.

OTHERS

360 360 Mifepristone 200 mg Tablets 1x10

361 361 Oxytocin Injection I.P. strength 5 iu / ml 1 ml Amp.

49

Annexure – VI

CHECK LIST COVER - A.

1. Checklist – Annexure VI Page No. Yes No

2. EMD in the form of DD shall be kept

in an envelope.

Page No. Yes No

3. Self attested and notorised Photo copy

of licence for Analytical laboratory

renewed upto date.

Page No. Yes No

4. Annexure – I

Proforma for performance statement

Page No. Yes No

5. Annexure – II

Details of Laboratory and Certificate

of Registration for service tax

Page No. Yes No

Annexure – III

Self attested and notorised of the following

documents:

6. Annexure – III (A)

Personnel in Laboratory.

Page No. Yes No

50

7. Annexure – III (B)

List of Sophisticated instruments.

Page No. Yes No

8. Annexure – III (C)

Facilities in Microbiological section

Page No. Yes No

9. Annexure – IV

Declaration form duly signed &

notorised.

Page No. Yes No

10. Annexure - V

List of Drugs and medicines

Page No. Yes No

11. Recognition Certificate issued

by NABL

Page No. Yes No

12. Certificate for analysis issued by other

recognized agencies

Page No. Yes No

13. Documentary evidence, for the

constitution of the company / laboratory

ie., Memorandum and articles of

Association or partnership etc.,

Page No. Yes No

14. The instruments such as power of

attorney, resolution of board etc.,

Page No. Yes No

51

15. Annual Turn over for the last two

years certified by the auditors.

Page No. Yes No

16. The tender document signed by the

tenderer in all pages with official seal

Page No. all Yes No

Cover B: (Price Bid) in a separate cover

17 Annexure VII Page No. Yes No

52

Annexure – VII

Price Bid

S.

No

.

Drug

Cod

e

Name of

Medicin

e

Rate

excludin

g Tax

Tax

applicab

le in %

Total

including

Taxes

Remark

s

Enclose Soft Copy of Price Bid (in Excel Sheet) in CD also.